AliveCor QT Service vs KardiaAI
AI Verdict
Choose AliveCor QT Service if…
Choose AliveCor QT Service if your primary need is precise and instant measurement of QT and QTc intervals from AliveCor 6-Lead ECGs. This tool is ideal for healthcare professionals who require accurate cardiac safety assessments to guide medication prescribing decisions, particularly when monitoring for drug-induced QT prolongation.
View AliveCor QT Service →Choose KardiaAI if…
Choose KardiaAI if you require a comprehensive AI-powered solution for detecting a wide range of common cardiac arrhythmias from ambulatory ECG rhythms. This tool is best suited for integration into existing mobile apps or web platforms, providing medical-grade accuracy for identifying conditions like AFib, bradycardia, tachycardia, and various ectopies.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AliveCor QT Service | KardiaAI |
|---|---|---|
| Pricing | Varies by product and service, with subscription options available. | Subscription-based for advanced features and services. |
| Deployment | Mobile app, cloud-based platform, EHR integration. | Mobile app, cloud-based. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
KardiaAIWhile Tool A integrates seamlessly into professional workflows via existing AliveCor platforms, Tool B, as an API library, powers the highly user-friendly KardiaMobile devices and the Kardia app. These integrated products are widely recognized for their ease of use by both patients and clinicians for self-monitoring and rapid rhythm detection, suggesting a broader and more direct usability impact for a wider range of users.
Clinical Value
AliveCor QT ServiceTool A provides instant, accurate QT and QTc interval measurements, directly enabling healthcare professionals to assess cardiac safety and inform critical medication prescribing decisions. This addresses a time-sensitive and potentially life-threatening risk associated with drug-induced QT prolongation, offering immediate and actionable clinical insights.
Pricing & Value
KardiaAITool B offers transparent, subscription-based pricing for its integrated services, with clear monthly and annual options. In contrast, Tool A requires contacting the vendor for pricing details, which makes its value proposition less immediately accessible and harder to compare. [cite: Tool A JSON, Tool B JSON]
Enterprise Readiness
TieBoth tools demonstrate high enterprise readiness, being FDA-cleared, HIPAA compliant, and offering BAAs. They both provide robust API integration capabilities for various healthcare systems and platforms, making them equally suitable for enterprise deployment. [cite: Tool A JSON, Tool B JSON, 3, 7, 9, 10]
Innovation
AliveCor QT ServiceWhile both leverage advanced AI, Tool A's specialized application of AI for instant and accurate QT/QTc interval measurement for medication safety addresses a unique and critical clinical need with high impact on patient safety. This real-time, precise cardiac safety assessment in a highly impactful clinical context demonstrates a slightly higher degree of focused innovation.
Support & Docs
KardiaAIAlthough the provided JSON is silent on this dimension for both tools, external information highlights that AliveCor's SDK, essential for integrating KardiaAI (Tool B), offers comprehensive technical documentation and an engaged engineering support team. This explicit support for developers is crucial for an API library's successful adoption.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AliveCor QT Service | KardiaAI |
|---|---|---|
| Name | AliveCor QT Service | KardiaAI |
| Company | AliveCor | AliveCor |
| Description | A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. | KardiaAI by AliveCor is an FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia. |
| Key Features (ECG Analysis) | Measures QT and QTc intervals (Bazett's and Fridericia's formulas); Utilizes AI and deep neural networks for ECG analysis; Provides instant QT measurements (as InstantQT) | Detection of atrial fibrillation, bradycardia, tachycardia, and normal sinus rhythm; Detection of Sinus Rhythm with Premature Ventricular Contractions (PVCs); Detection of Sinus Rhythm with Wide QRS; Detection of Sinus Rhythm with Supraventricular Ectopy (SVE); ECG noise filtering and noisy ECG detection |
| Integration | Integrates with KardiaStation app and KardiaPro portal; API available for integration with EHR, SDK, CRM, EDC, and PSP platforms | API library for integration into other ECG devices and software |
| Categories | Cardiology AI, Pharmacology & Dosing AI | Cardiology AI |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Emergency Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring AliveCor QT Service and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring AliveCor QT Service or KardiaAI
Backers
Who funded each tool's parent company.